PGP and cervical carcinoma: Yamagishi et al. [8] used the human cervical carcinoma-derived (KB31) cell line and the vinblastine-resistant (Pgp-overexpressing) variant KBV1 and reported Pgp-mediated lysosomal drug trapping only in KBV1 cells.